108Labs

108Labs is leading the way in cell-cultured mammalian milk production, with a focus on developing Colostrupedics™ whole-human infant formula and other dairy products. Established in 2013, the company created the first cell-cultured human milk in January 2020 and is now focused on scaling up production through the buildout of the first smart Cellufacturing plant. This cutting-edge facility incorporates software, AI, hardware, and biotechnology to produce cell-cultured mammalian milk products at an industrial level. Their flagship product, Colostrupedics whole-human infant formula, is expected to revolutionize the infant nutrition market. While specifics about recent investments and investors are not currently available, 108Labs' positioning within the Biopharma, Biotechnology, and Pharmaceutical industries, combined with their headquarters in the United States, underscores their potential for significant impact within the food tech sector.